Showing results (131-140 of 318) with videos related to
Sort By:
Pageof 32
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|October 12, 2013
[Local treatment combined with EGFR-TKIs for advanced non-small cell lung cancer with solitary progression during EGFR-TKI treatment]Xin Zhang, Bin Wang, Lin Lin, et al.Toxics|February 26, 2026
Advances and Challenges in Understanding Atmospheric Oxidizing Capacity in China: Insights from Chemical Mechanisms and Model ApplicationsPeixuan Li, Yanqin Ren, Fang Bi, et al.Oncotarget|July 16, 2016
Responses to crizotinib in patients with ALK-positive lung adenocarcinoma who tested immunohistochemistry (IHC)-positive and fluorescence in situ hybridization (FISH)-negativeDi Ma, Zheng Wang, Lin Yang, et al.Mechanisms of Development|April 21, 2015
A transgenic zebrafish model for monitoring xbp1 splicing and endoplasmic reticulum stress in vivoJunling Li, Zhiliang Chen, Lian-Yong Gao, et al.Journal of Nuclear Medicine Technology|July 2, 2016
In Vitro PET Imaging of a Miniature Ventricular Assist DeviceMichael S Gossman, Joel D Graham, Stephen Depot, et al.Nuclear Medicine and Biology|December 25, 2014
Characterization of (18)F-dipicolylamine (DPA) derivatives in cells infected with influenza virusJunling Li, Rachael L Gerlach, Colleen B Jonsson, et al.Thoracic Cancer|September 14, 2022
Adjuvant chemotherapy in patients with recurrence after completely resected stage IB lung adenocarcinoma: Propensity-matched analysis in a cohort of 147 recurrencesFei Xu, Heng-Chi Chen, Haiyan Xu, et al.Journal of Genetics and Genomics = Yi Chuan Xue Bao|February 25, 2012
Functional analysis of slow myosin heavy chain 1 and myomesin-3 in sarcomere organization in zebrafish embryonic slow musclesJin Xu, Jie Gao, Junling Li, et al.Biochemical and Biophysical Research Communications|October 3, 2003
Role of class I and class II histone deacetylases in carcinoma cells using siRNAKeith B Glaser, Junling Li, Michael J Staver, et al.Thoracic Cancer|March 29, 2019
Favorable predictors for survival in advanced ALK-positive non-small cell lung cancer patients beyond crizotinib resistanceHaiyan Xu, Guangjian Yang, Lu Yang, et al.Pageof 32